Search for: "AD GLOBAL FUND V US" Results 181 - 200 of 702
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2011, 4:27 am by Marie Louise
(TTABlog) (Patent Arcade) (Property, intangible)   Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
12 Feb 2021, 3:00 am by Jim Sedor
Krein helps oversee StartUp Health investments in hundreds of companies, including some hoping to break through with the federal agencies battling the global coronavirus pandemic. [read post]
28 Sep 2011, 1:56 am by Marie Louise
  Highlights this week included: US: CAFC: Patent exhaustion does not apply to genetically engineered seed: Monsanto Co. v. [read post]
14 Oct 2020, 2:32 pm by John Elwood
That brings us to Lange v. [read post]
10 Nov 2010, 1:11 am by Kelly
Becton-Dickinson (Patent Docs) US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) US: BIO and AUTM fire back at gene patent foes – AMP v USPTO (Patent Baristas) (Patent Docs) US: IPO files amicus brief in AMP v USPTO (Patent Docs) (Patent Baristas) US: AIPLA submits amicus brief in AMP v… [read post]
3 Aug 2011, 3:31 am by Marie Louise
Patent and Trademark Office (Holman’s Biotech IP Blog) US: Myriad writes to CAFC on standing issue (Patent Docs) (Patent Docs) (Holman’s Biotech IP Blog) US: In the first 7 months of 2011, the FDA has approved 18 new molecular entity pharmaceutical drugs (and no biologic NMEs) (KEI) US: Embryonic stem cell funding suit dead: Sherley v. [read post]
19 Jan 2023, 11:16 am by Cory Doctorow
This is true even - especially - if the bullies use some of that stolen lunch money to pay for a massive global ad campaign exhorting us to think of the poor hungry kids and demanding that we give them even more lunch money. [read post]
23 Jan 2024, 9:01 pm by renholding
Allianz Allianz Global’s $145 million payout benefits shareholders of collapsed mutual funds that Allianz managed. [read post]
Elbaz and her partners solicited investors via false internet ads, lied to investors about the nature of their highly risky investments, and refused to allow investors to withdraw their funds. [read post]
30 Aug 2010, 1:17 am by Kelly
Highlights this week included: ECJ Advocate General says no to a single EU patent litigation system (IAM) (EPLAW) (IPBiz) (IPKat) (PatLit) (IP:JUR) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
26 Oct 2014, 5:00 am by Barry Sookman
blogged: Computer and Internet Law Weekly Updates for 2014-10-18 http://t.co/fLXIX1Pwvp -> Computer and Internet Law Weekly Updates for 2014-10-18: Cyberbullying bill inches closer to law despite priva… http://t.co/Jt8xEVdzzh -> Cambridge, Oxford, Sage v GSU Appeals court overturns finding of fair use http://t.co/QF45fOhUbQ -> Negative online reviews can lead to threats of legal action from targeted businesses http://t.co/HtNAiZqizF -> How foreign online… [read post]
10 Apr 2016, 4:00 am by Barry Sookman
GOOGLE opinion on using social media to vet jurors https://t.co/vQ2NKRw75m -> Domain name intangible property subject to garnishment SPRINKLER v. [read post]
5 Jun 2020, 3:00 am by Jim Sedor
Campaign Funds for Judges Warp Criminal Justice, Study Finds New York Times – Adam Liptak | Published: 6/1/2020 In Gideon v. [read post]
4 May 2011, 4:13 am by Marie Louise
Highlights this week included: Provigil (Modafinil) – EU announces anti-trust probe into a Cephalon – Teva deal concerning generic Provigil (The IP Factor) (GenericsWeb) Court of Appeals for District of Columbia lifts injunction on federal funding of embryonic stem-cell research: Sherley et al v Kathleen Sebelius et al (Patent Baristas) (Ars Technica) (SCOTUSblog) India: PM instructs negotiators – no TRIPS plus IP obligation in EU FTA (Generic Pharmaceuticals and… [read post]